CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Cardene In 5.0% Dextrose In Plastic Container patents expire, and when can generic versions of Cardene In 5.0% Dextrose In Plastic Container launch?
Cardene In 5.0% Dextrose In Plastic Container is a drug marketed by Chiesi and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.
This drug has twenty-one patent family members in ten countries.
The generic ingredient in CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cardene In 5.0% Dextrose In Plastic Container
A generic version of CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER was approved as nicardipine hydrochloride by ANI PHARMS on October 28th, 1996.
Summary for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
International Patents: | 21 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 8 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2 |
University of Cincinnati | Phase 2 |
Vanderbilt University Medical Center | Phase 2 |
See all CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER clinical trials
Pharmacology for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
Anatomical Therapeutic Chemical (ATC) Classes for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
Paragraph IV (Patent) Challenges for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER | Injection | nicardipine hydrochloride | 2.5 mg/mL, 10 mL Ampoules | 019734 | 1 | 2006-12-27 |
US Patents and Regulatory Information for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER is protected by four US patents.
Patents protecting CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
Pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD FOR TREATING ACUTE ELEVATIONS OF BLOOD PRESSURE IN HUMAN SUBJECT IN NEED THEREOF
Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD FOR TREATING ACUTE ELEVATIONS OF BLOOD PRESSURE IN HUMAN SUBJECT IN NEED THEREOF
Pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
International Patents for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
See the table below for patents covering CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S504082 | ⤷ Try a Trial | |
South Korea | 20090040258 | PRE-MIXED, READY-TO-USE PHARMACEUTICAL COMPOSITIONS | ⤷ Try a Trial |
Japan | S49109384 | ⤷ Try a Trial | |
European Patent Office | 2018152 | COMPOSITIONS PHARMACEUTIQUES PRÉMÉLANGÉES PRÊTES À L'EMPLOI (PRE-MIXED, READY-TO-USE PHARMACEUTICAL COMPOSITIONS) | ⤷ Try a Trial |
Spain | 8700567 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |